(Q28190339)

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Decreased IL-12 production and Th1 cell development by acetyl salicylic acid-mediated inhibition of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Whole-blood lymphocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

The actions of NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Hexokinase-inhibition and lymphocyte transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

A review of mechanism of action of aspirin and its potential as an immunomodulating agent

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Prostaglandin modulation of development of cell-mediated immunity in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

The effect of acetylsalicylic acid on the metabolism and transformability of human lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Suppression of lymphocyte transformation by aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Immunosuppressive actions of prostaglandins and the possible increase in chronic inflammation after cyclo-oxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Modulation of rat and human lymphocyte function by n-6 and n-3 polyunsaturated fatty acids and acetylsalicylic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Inhibition of phytohaemagglutinin-induced lymphocyte proliferation by immunosuppressive drugs: use of whole blood culture

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Clinical pharmacokinetics of salicylates: a re-assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

The European Stroke Prevention Study: Results according to sex

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

A randomized trial of aspirin and sulfinpyrazone in patients with TIA

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

The effects of age and sex on the disposition of acetylsalicylic acid and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Identification and partial purification of the major aspirin hydrolyzing enzyme in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

Evidence for a Sex-linked Difference in Aspirin Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021

The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900132-1

7 January 2021